Form 8-K - Current report:
SEC Accession No. 0001437749-24-033217
Filing Date
2024-11-05
Accepted
2024-11-05 09:29:40
Documents
14
Period of Report
2024-11-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20241030_8k.htm   iXBRL 8-K 27085
  Complete submission text file 0001437749-24-033217.txt   158379

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20241104.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20241104_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20241104_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20241104_pre.xml EX-101.PRE 11585
16 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20241030_8k_htm.xml XML 2824
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 241425987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)